Carl A. B. Pearson

16.4k total citations · 1 hit paper
41 papers, 1.1k citations indexed

About

Carl A. B. Pearson is a scholar working on Modeling and Simulation, Infectious Diseases and Health. According to data from OpenAlex, Carl A. B. Pearson has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Modeling and Simulation, 15 papers in Infectious Diseases and 7 papers in Health. Recurrent topics in Carl A. B. Pearson's work include COVID-19 epidemiological studies (19 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Vaccine Coverage and Hesitancy (7 papers). Carl A. B. Pearson is often cited by papers focused on COVID-19 epidemiological studies (19 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Vaccine Coverage and Hesitancy (7 papers). Carl A. B. Pearson collaborates with scholars based in United Kingdom, United States and South Africa. Carl A. B. Pearson's co-authors include Samuel Clifford, Simon R. Procter, Emily Nightingale, Naomi R. Waterlow, Yalda Jafari, Eleanor M. Rees, Gwenan M. Knight, Thibaut Jombart, Thomas J. Hladish and Akira Endo and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Carl A. B. Pearson

37 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heavy-tailed sexual contact networks and monkeypox epidemiology in the global outbreak, 2022

2022 112 citations Akira Endo, Sam Abbott et al. Science profile →

Peers

Countries citing papers authored by Carl A. B. Pearson

Since Specialization

Citations

This map shows the geographic impact of Carl A. B. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl A. B. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl A. B. Pearson more than expected).

Fields of papers citing papers by Carl A. B. Pearson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl A. B. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl A. B. Pearson. The network helps show where Carl A. B. Pearson may publish in the future.

Co-authorship network of co-authors of Carl A. B. Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of Carl A. B. Pearson. A scholar is included among the top collaborators of Carl A. B. Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl A. B. Pearson. Carl A. B. Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Agent-based modeling of the COVID-19 pandemic in Florida 2024 ·Epidemics ·(unknown), Kok Ben Toh, (unknown), (unknown), Arlin Stoltzfus, Ira M. Longini, Carl A. B. Pearson, Thomas J. Hladish	6
2	What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria 2023 ·SHILAP Revista de lepidopterología ·Francis Ruiz, Sergio Torres‐Rueda, Carl A. B. Pearson, (unknown), Chinyere Okeke, Simon R. Procter, (unknown), Mark Jit, Anna Vassall, Benjamin Uzochukwu	7
3	Assessing the impacts of COVID-19 vaccination programme’s timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries 2023 ·BMC Medicine ·Yang Liu, Simon R. Procter, Carl A. B. Pearson, (unknown), Sergio Torres‐Rueda, (unknown), Benjamin Uzochukwu, Tom Drake, (unknown), Rosalind M. Eggo, Francis Ruiz, Nicaise Ndembi, Justice Nonvignon, Mark Jit, Anna Vassall	18
4	Increased rates of hospital-onset Staphylococcus aureus bacteraemia in National Health Service acute trusts in England between June 2020 and March 2021: a national surveillance review 2023 ·Journal of Hospital Infection ·(unknown), Olisaeloka Nsonwu, Jocelyn Elmes, Dimple Chudasama, Carl A. B. Pearson, (unknown), Russell Hope, Sarah Gerver	2
5	A Scoping Review and Taxonomy of Epidemiological-Macroeconomic Models of COVID-19 2023 ·Value in Health ·(unknown), Carl A. B. Pearson, Sergio Torres‐Rueda, Francis Ruiz, Jo Lines, Mark Jit, Anna Vassall, Sedona Sweeney	4
6	Heavy-tailed sexual contact networks and monkeypox epidemiology in the global outbreak, 2022 breakdown → 2022 ·Science ·Akira Endo, (unknown), Sam Abbott, Ruwan Ratnayake, Carl A. B. Pearson, W. John Edmunds, Elizabeth Fearon, Sebastian Funk	112
7	Effect of Population Partitioning on the Probability of Silent Circulation of Poliovirus 2022 ·Bulletin of Mathematical Biology ·(unknown), Carl A. B. Pearson, James S. Koopman, Thomas J. Hladish	1
8	Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis 2022 ·The Lancet Regional Health - Europe ·Yang Liu, Carl A. B. Pearson, Frank Sandmann, Rosanna C. Barnard, Jonghoon Kim, Stefan Flasche, Mark Jit, Kaja Abbas	18
9	Potential test-negative design study bias in outbreak settings: application to Ebola vaccination in Democratic Republic of Congo 2021 ·International Journal of Epidemiology ·Carl A. B. Pearson, W. John Edmunds, Thomas J. Hladish, Rosalind M. Eggo	2
10	Detecting behavioural changes in human movement to inform the spatial scale of interventions against COVID-19 2021 ·PLoS Computational Biology ·Hamish Gibbs, Emily Nightingale, Yang Liu, James Cheshire, León Danon, Liam Smeeth, Carl A. B. Pearson, Chris Grundy, (unknown), Adam J. Kucharski, Rosalind M. Eggo	25
11	COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness 2021 ·PLoS Medicine ·Carl A. B. Pearson, Fiammetta Bozzani, Simon R. Procter, Nicholas G. Davies, (unknown), Henning Tarp Jensen, Marcus Keogh-Brown, (unknown), Sedona Sweeney, Sergio Torres‐Rueda, (unknown), (unknown), Rosalind M. Eggo, Anna Vassall, Mark Jit	34
12	Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region: a mathematical modelling study 2021 ·The Lancet Regional Health - Europe ·Yang Liu, Frank Sandmann, Rosanna C. Barnard, Carl A. B. Pearson, Roberta Pastore, Richard Pebody, Stefan Flasche, Mark Jit	29
13	Strategies to reduce the risk of SARS-CoV-2 importation from international travellers: modelling estimations for the United Kingdom, July 2020 2021 ·Eurosurveillance ·Samuel Clifford, Billy J. Quilty, Timothy Russell, Yang Liu, Y. Chan, Carl A. B. Pearson, Rosalind M. Eggo, Akira Endo, (unknown), Stefan Flasche, W. John Edmunds	18
14	Effectiveness of interventions targeting air travellers for delaying local outbreaks of SARS-CoV-2 2020 ·Journal of Travel Medicine ·Samuel Clifford, Carl A. B. Pearson, Petra Klepac, Kevin van Zandvoort, Billy J. Quilty, (unknown), Rosalind M. Eggo, Stefan Flasche	34
15	Evaluating the probability of silent circulation of polio in small populations using the silent circulation statistic 2019 ·Infectious Disease Modelling ·(unknown), Carl A. B. Pearson, James S. Koopman, Thomas J. Hladish	4
16	Forecasting the effectiveness of indoor residual spraying for reducing dengue burden 2018 ·PLoS neglected tropical diseases ·Thomas J. Hladish, Carl A. B. Pearson, Diana P. Rojas, Hector Gómez‐Dantés, M. Elizabeth Halloran, Gonzalo M. Vazquez‐Prokopec, Ira M. Longini	40
17	Projected Impact of Dengue Vaccination in Yucatán, Mexico 2016 ·PLoS neglected tropical diseases ·Thomas J. Hladish, Carl A. B. Pearson, Dennis L. Chao, Diana P. Rojas, Gabriel Recchia, Hector Gómez‐Dantés, M. Elizabeth Halloran, Juliet R.C. Pulliam, Ira M. Longini	38
18	Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis 2015 ·The Lancet Infectious Diseases ·Steven E. Bellan, Juliet R.C. Pulliam, Carl A. B. Pearson, David Champredon, Spencer J. Fox, Laura Skrip, Alison P. Galvani, Manoj Gambhir, Ben Lopman, Travis C. Porco, Lauren Ancel Meyers, Jonathan Dushoff	46
19	The Coventry story of regeneration in an age of austerity: A practitioner’s perspective 2014 ·Journal of urban regeneration and renewal ·Carl A. B. Pearson	1
20	Network Class Superposition Analyses 2013 ·PLoS ONE ·Carl A. B. Pearson, Chen Zeng, Rahul Simha	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact